share_log

Immuron Ltd: Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5 14:10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.